[go: up one dir, main page]

WO2008068577A3 - Compositions pharmaceutiques - Google Patents

Compositions pharmaceutiques Download PDF

Info

Publication number
WO2008068577A3
WO2008068577A3 PCT/IB2007/003705 IB2007003705W WO2008068577A3 WO 2008068577 A3 WO2008068577 A3 WO 2008068577A3 IB 2007003705 W IB2007003705 W IB 2007003705W WO 2008068577 A3 WO2008068577 A3 WO 2008068577A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
diuretic
angiotensin
ace
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/003705
Other languages
English (en)
Other versions
WO2008068577A2 (fr
Inventor
Nilendu Sen
Sunil Mirajkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Pharmaceuticals Ltd
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2008068577A2 publication Critical patent/WO2008068577A2/fr
Publication of WO2008068577A3 publication Critical patent/WO2008068577A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une composition pharmaceutique solide comprenant (a) un diurétique ; et (b) un inhibiteur de l'enzyme de conversion de l'angiotensine (ECA), environ 100 % des tailles de particules du diurétique passant dans un tamis présentant un maillage standard de 60#.
PCT/IB2007/003705 2006-12-01 2007-11-30 Compositions pharmaceutiques Ceased WO2008068577A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1987/MUM/2006 2006-12-01
IN1987MU2006 2006-12-01
US87387506P 2006-12-08 2006-12-08
US60/873,875 2006-12-08

Publications (2)

Publication Number Publication Date
WO2008068577A2 WO2008068577A2 (fr) 2008-06-12
WO2008068577A3 true WO2008068577A3 (fr) 2009-04-23

Family

ID=39492669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003705 Ceased WO2008068577A2 (fr) 2006-12-01 2007-11-30 Compositions pharmaceutiques

Country Status (1)

Country Link
WO (1) WO2008068577A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653336B1 (en) * 1997-11-19 2003-11-25 Les Laboratoires Servier Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
WO2005094793A1 (fr) * 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Procede de preparation d'une composition pharmaceutique solide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653336B1 (en) * 1997-11-19 2003-11-25 Les Laboratoires Servier Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
WO2005094793A1 (fr) * 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Procede de preparation d'une composition pharmaceutique solide

Also Published As

Publication number Publication date
WO2008068577A2 (fr) 2008-06-12

Similar Documents

Publication Publication Date Title
AU2003240947A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2007134279A3 (fr) Compositions de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoléine-3-carboxamide
AU2003206146A1 (en) Composition of environmental friendly neuter loaded stream extinguisher for ordinary fire (a class) and method for preparing the same
EP1920754A3 (fr) Compositions rendues non collantes
WO2006020994A3 (fr) Compositions et methodes utilisant de l'acide hyaluronique
IL183689A0 (en) Pharmaceutical compositions and kits for improving the structure and function of arterioles
WO2007098352A3 (fr) Pyridineamides substitués pouvant être employés en tant qu'inhibiteurs d'époxyde hydrolase soluble
AU2003299480A1 (en) Pharmaceutical composition including low dosages of desmopressin
AU2003259155A1 (en) Pharmaceutical compositions comprising hepatitis c viral protease inhibitors
AU2003265859A1 (en) Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
WO2008042126A3 (fr) Loupe pour forme
AU2003302653A1 (en) Polymer compound, resist composition and dissolution inhibitor agent containing the polymer compound
AU2003291828A1 (en) Microspheres and related processes and pharmaceutical compositions
WO2005114452A3 (fr) Architecture orientee services
AU2003291443A1 (en) Compositions and processes for nanoimprinting
WO2005011652A3 (fr) Utilisation de vitamines d pour le traitement de maladie rénale
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
WO2008068577A3 (fr) Compositions pharmaceutiques
AU2003290417A1 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
MX2009005077A (es) Composicion absorbente para tratamiento de superficies.
WO2007022321A3 (fr) Indoles substitues et procedes d'utilisation de ceux-ci
AU2002354197A1 (en) Fuel composition
WO2001000183A3 (fr) COMBINAISON D'INHIBITEURS DE MTP (PROTEINE DE TRANSFERT MICROSOMALE) ET INHIBITEURS DE HMG-CoA-REDUCTASE ET LEUR UTILISATION DANS DES MEDICAMENTS
WO2008001184A3 (fr) Composition solide
WO2006128469A3 (fr) Melanges de particules inactives et de particules actives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848962

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07848962

Country of ref document: EP

Kind code of ref document: A2